###
中国临床研究英文版:2025,38(2):289-293
本文二维码信息
码上扫一扫!
清消方联合拔毒生肌散药线挂线治疗肝经郁热证非哺乳期乳腺炎乳晕部瘘管的临床疗效
(南京中医药大学附属医院 江苏省中医院乳腺外科,江苏 南京 210029)
Clinical effect of Qingxiao Formula combined with silk seton therapy by applying Badu Shengji Powder on areola fistula of non-lactating mastitis with liver meridian stagnation heat syndrome
(Department of Breast Surgery, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210029, China)
摘要
本文已被:浏览 403次   下载 51
Received:February 19, 2024   Published Online:February 20, 2025
中文摘要: 目的 观察肝经郁热证非哺乳期乳腺炎乳晕部瘘管患者应用清消方联合拔毒生肌散药线挂线治疗的临床疗效。方法 选择2018年10月至2020年12月江苏省中医院乳腺外科门诊就诊的非哺乳期乳腺炎乳晕部瘘管患者60例作为研究对象,采用区组随机、临床对照试验方法,按1∶1分为观察组及对照组,每组30例。两组均口服清消方,观察组加用拔毒生肌散药线挂线治疗,对照组加用普通丝线挂线治疗,每隔3~4d挂线1次,共挂4次。测量瘘管口的大小、红肿范围,填写视觉模拟疼痛评分量表(VAS)。观察两组患者的痊愈时间、瘘管全部挂开时间、VAS评分及安全性指标(血常规及肝肾功能)等,并随访复发情况。结果 在挂线治疗第3次时,观察组的瘘管口挂开长度长于对照组,差异有统计学意义(P<0.05)。与对照组比较,观察组瘘管挂开时间 [(12.00±2.22)d vs (14.46±3.76)d, t=3.860, P<0.01]、痊愈时间[(19.75±2.94)d vs (23.40±3.22)d, t=4.585, P<0.01]更短。随着挂线治疗次数的增加,瘘管被逐渐挂开,两组患者挂线治疗的疼痛均明显减轻(P<0.05),但组间比较差异无统计学意义(P>0.05)。两组患者均未发生不良反应。结论 清消方联合拔毒生肌散药线挂线治疗肝经郁热证非哺乳期乳腺炎乳晕部瘘管的疗效确切,可缩短瘘管挂开时间,加快痊愈时间,伤口感染率和复发率均较低。
Abstract:Objective To observe the clinical effect of Qingxiao Formula combined with silk seton therapy by applying Badu Shengji Powder on areola fistula of non-lactating mastitis with liver meridian stagnation heat syndrome. Methods Sixty patients with non-lactation mastitis and areolar fistula who visited the Department of Breast Surgery at Jiangsu Province Hospital of Chinese Medicine from October 2018 to December 2020 were selected as the research subjects. A block randomization, controlled clinical trial method was employed. The participants were divided into an observation group and a control group at a ratio of 1∶1, with 30 cases in each group. Both groups received oral administration of Qingxiao Formula. The observation group was additionally treated with silk seton therapy by applyin Badu Shengji Powder,while the control group was treated with traditional silk seton therapy. The setons were replaced every three or four days, for a total of four replacements. The recovery time, fistula opening time, VAS score and safety indicators (blood routine, liver and kidney function) of the two groups were observed, and the recurrence of the patients was followed up. Results At the third seton therapy, the length of the fistula opening in the oberration group was significantly longer than that in the control group, with a statistically significant difference (P<0.05). Compared with the control group, the observation group had a shorter time of fistula complete opening [(12.00±2.22)d vs (14.46±3.76)d,t=3.860,P<0.01] and fistula healing [(19.75±2.94)d vs (23.40±3.22)d,t=4.585,P<0.01]. With the increase of the number of seton therapy, the fistula was gradually opened, and the pain from the seton therapy obviously relieved in both groups (P<0.05), but there was no statistical difference between the two groups (P>0.05). No adverse reactions occurred in either group of patients. Conclusion The combination of Qingxiao Formula and silk seton therapy by applying Badu Shengji Powder is an effective treatment for non-lactation mastitis with areolar fistula in liver meridian stagnation heat syndrome, which can shorten the time required for the fistula to open completely, accelerate healing, reduce the rate of wound infection, and decrease recurrence.
文章编号:     中图分类号:R269    文献标志码:A
基金项目:江苏省中医院院级创新发展基金专项课题(Y2108CX26)
引用文本:


Scan with WeChat

Scan with WeChat